Ogai M, Iyo M, Mori N, Takei N.
Right orbitofrontal region and obsessive-compulsive behavior : a case report.
Acta Psychiatr Scand 111: 74-76, 2005.
Sekine Y, Takei N, Suzuki K, Nakamura K, Tsuchiya KJ, Takebayashi K, Toulopoulou
T, Mori N.
Effective adjunctive use of pergolide with quetiapine for cognitive impairment
and negative symptoms in schizophrenia.
J Clin Psychopharmacol 25: 281-283, 2005.
Takei N, Takagai S, Mori N.
Stigmatisation of people with schizophrenia in Japan.
Br J Psychiatr 187:589-590, 2005.
Tsuchiya KJ, Agerbo E, Mortensen PB.
Parental death and bipolar disorder: a robust association was found in
early maternal suicide.
J Affect Disord 86: 151-159, 2005.
Tsuchiya KJ, Takagai S, Kawai M, Matsumoto H, Mori N, Takei N.
Advanced paternal age associated with an elevated risk for schizophrenia
in offspring in a Japanese population.
Schizophr Res 76: 337-342, 2005.
Arai M, Yamada K, Toyota T, Obata N, Haga S, Yoshida Y, Nakamura K, Minabe
Y, Ujike H, Sora I, Ikeda K, Mori N, Yoshikawa T, Itokawa M.
Association between polymorphisms in the promoter region of the sialyltransferase 8B (SIAT8B) gene and schizophrenia.
Biol Psychiatry 59: 652-659, 2005.
Hashimoto K, Shimizu E, Komatsu N, Watanabe H, Shinoda N, Nakazato M, Kumakiri
C, Okada S, Takei N, Iyo M.
No changes in serum epidermal growth factor levels in patients with schizophrenia.
Psychiatr Res 135:257-260, 2005.
Hashimoto T, Hashimoto K, Matsuzawa D, Shimizu E, Sekine Y, Inada T, Ozaki
N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iyo M.
A functional glutathione-S-transferase P1 polymorphism is associated with
methamphetamine-induced psychosis in Japanese population.
Am J Med Genet 35:5-9, 2005.
Ide M, Yamada K, Toyota T, Iwayama Y, Ishitsuka Y, Minabe Y, Nakamura K,
Hattori N, Asada T, Mizuno Y, Mori N, Yoshikawa T.
Genetic association analyses of PHOX2B and ASCL1 in neuropsychiatric disorders:
evidence for association of ASCL1 with Parkinson's disease.
Hum Genet 117: 520-527, 2005.
Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y, Sekine
Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Inada T, Ozaki
N.
Positive association of AKT1 haplotype to Japanese methamphetamine use
disorder.
Int J Neuropsychopharmacol 28: 1-5, 2005.
Itoh K, Hashimoto K, Shimizu E, Sekine Y, Ozaki N, Inada T, Harano M, Iwata N, Komiyama T, Yamada M, Sora I, Nakata K, Ujike H, Iyo M.
Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan.
Am J Med Genet B Neuropsychiatr Genet 132(1):70-73, 2005.
Iwayama SY, Yamada K, Itokawa M, Toyota T, Meerabux JM, Minabe Y, Mori
N, Inada T,Yoshikawa T.
Extended analyses support the association of functional (GT)n polymorphism
in the GRIN2A promoter with Japanese schizophrenia.
Neurosci Lett 378: 102-105.2005.
Kakiuchi C, Ishiwata M, Nanko S, Kunugi H, Minabe Y, Nakamura K, Mori N,
Fujii K, Umekage T, Tochigi M, Kohda K, Sasaki T, Yamada K, Yoshikawa T,
Kato T.
Functional polymorphism of HSPA5: Possible association with bipolar disorder.
Biochem Biophys Res Commun 336:1136-1143, 2005.
Kato T, Iwayama Y, Kakiuchi C, Iwamoto K, Yamada K, Minabe Y, Nakamura K, Mori N, Fujii K, Nanko S, Yoshikawa T.
Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia.
Mol Psychiatry 10: 1045-1055, 2005.
Morita Y, Ujike H, Tanaka Y, Uchida N, Nomura A, Otani K, Kishimoto M,
Morio A, Inada T, Harano M, Komiyama T, Yamada M, Sekine Y, Iwata N, Iyo
M, Sora I, Ozaki N.
The X-box binding protein 1 (XBP1) gene is not associated with
methamphetamine dependence.
Neurosci Lett 383: 194-198, 2005.
Nishiyama T, Ikeda M, Iwata N, Suzuki T, Kitajima T, Yamanouchi Y, Sekine
Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Inada T, Furukawa
T, Ozaki N.
Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder.
Pharmacogenomics J 5:89-95, 2005.
Ohgake S, Hashimoto K, Shimizu E, Koizumi H, Okamura N, Koike K, Matsuzawa D, Sekine Y, Inada T, Ozaki N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Shirayama Y, Iyo M.
Functional polymorphism of the NQO2 gene is associated with methamphetamine
psychosis. Addict Biol 10: 145-148, 2005.
Ouchi Y, Yoshikawa E, Kanno T, Futatsubashi M, Sekine Y, Okada H, Torizuka
T, Tanaka K.
Orthostatic posture affects brain hemodynamics and metabolism in cerebrovascular disease patients with and without coronary artery disease: a positron emission tomography study.
Neuroimage 24: 70-81, 2005.
Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, Torizuka
T.
Microglial activation and dopamine terminal loss in early Parkinson's disease.
Ann Neurol 57: 168-175, 2005.
Ujike H, Inada T, Harano M, Komiyama T, Yamada M, Sekine Y, Iwata N, Iyo
M, Sora I,Ozaki N.
Candidate gene analysis of methamphetamine-related disorders.
Neuropsychopharmacol 30: S24-S25, 2005.
Yamada K, Ohnishi T, Hashimoto K, Ohba H, Iwayama-Shigeno Y, Toyoshima
M, Okuno A, Takao H, Toyota T, Minabe Y, Nakamura K, Shimizu E, Itokawa
M, Mori N, Iyo M, Yoshikawa T.
Identification of multiple serine racemase (SRR) mRNA isoforms and genetic
analyses of SRR and DAO in schizophrenia and D-serine levels.
Biol Psychiatry 57:1493-1503, 2005.
Kawai M, Takei N, Murray RM.
Have recent studies of the seasonality of birth in schizophrenia added
to our knowledge of
the disease? In: Infection and Psychiatric Disorder, eds. Fatemi SH, Machon RA. Taylor & Francis, pp 1-10, 2005
|
主な研究とプロジェクト
